Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycine for Prodromal Schizophrenia Symptoms
NCT00268749Phase 2Completed
- Sponsor
- Yale University
- Start
- Jul 2002
- Primary completion
- Nov 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of glycine in schizophrenia, sponsored by Yale University. Started Jul 2002; status: completed.
02
Drugs
glycine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00268749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268749.